Fig. 1From: Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort studyAn example of SMI delineating. a Shows a male patient without sarcopenia (SMI = 57.6 cm2/m2), whereas b shows the same patient with sarcopenia (SMI = 47.9 cm2/m2) at follow-upBack to article page